UGC
Positron Emission Tomography Devices (PET) Market Growth, Size and Share Analysis By Product Type (Full Ring and Partial Ring PET Scanners), Applications (Cardiology, Oncology, Neurology, and Others), End User (Hospitals, and Others) – Global Forecast Till 2023Positron Emission Tomography Devices (PET) Market HighlightsThe global positron emission tomography devices (PET) market growth is expected to rise at an approximate CAGR of 5.6% during forecast period, 2018–2023.According to the 2018 data suggested by the Australian Institute of Health and Welfare, around 5,091 new cases of head and neck cancer were diagnosed and around 1,034 number of deaths occurred from head and neck cancer in Australia.Increasing cases of head and neck cancer is the key factor driving the positron emission tomography devices (PET) market.Various other factors such as increasing cases of cancer, technological advancements, presence of a large target patient population and rising patient awareness regarding the benefits of positron emission tomography scanning are also expected to propel the growth of the market.However, stringent regulatory guidelines, cost associated with PET scan, and shorter half-life of radioisotopes can hamper the market growth over the forecast period.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7254Positron Emission Tomography Devices (PET) Market SegmentationThe global positron emission tomography devices (PET) market is segmented based on product type, applications, end user and region.The global market for positron emission tomography devices (PET), by product type is segmented into full ring PET scanners and partial ring PET scanners.The market, by applications, is segmented into cardiology, neurology, oncology, orthopaedics, urology, gastroenterology, and othersBased on end user, positron emission tomography devices (PET) market is segmented into hospitals, clinics, diagnostic centres, and others.Positron Emission Tomography Devices (PET) Market Regional AnalysisThe Americas dominated the global market for positron emission tomography devices (PET) owing to presence of major market players and increased prevalence of Alzheimer's dementia within the region.As per the data suggested by the Alzheimer's Association, an estimated 5.7 million Americans of all ages are living with Alzheimer's dementia in 2018.Europe is expected to hold the second largest position in the global positron emission tomography devices (PET) market.The market growth in this region is attributed to the government support and improving healthcare related research & development activities.Asia Pacific was projected to be the fastest growing region in 2017.
UGC
Market OverviewAccording to a new report by Market Research Future (MRFR), the global Gallstone Market has been anticipated to expand at 7.9 % CAGR during the forecast period (2017-2022) owing to the increase in gallbladder diseases globally.Gallstones develop due to chemical imbalance of bile inside the gallbladder.It has been predicted that in the UK, more than one in every ten adults suffer from gallstones.Several companies are also adopting strategies for acquisitions and launching new products to strive in the competitive market.The most common type is the cholesterol gallstone which appears in yellow and is mainly composed of undissolved cholesterols.According to World Gastroenterology Organisation, more than 85 % gallstones are cholesterol stones in developed countries, among which around 20 million people in the US suffer from gallstones.Different diagnostic procedures covered in the market include abdominal CT scan, ultrasound, blood tests, gallbladder radionuclide scan, and others.
UGC
 A detailed study on ‘Intravascular Catheter Market Size’, formulated by Market Research Future, offers an in-depth analysis of the key factors impacting the current business scenario across key regions.Intravascular Catheter Market Research Report: Information by Product (Short PIVC Catheters and Integrated/Closed PIVC Catheters), Application (Renal Disease, Cancer, Gastrointestinal Diseases, Infectious Diseases and other Diseases), End User (Hospitals, Clinics, Ambulatory Surgical Centers, Homecare and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) – Forecast till 2024 Market SegmentationThe global intravascular catheter market is broadly bifurcated on the basis of product, application, and end-user.Based on the product, the global market is diversified into integrated/closed PIVC catheters and short PIVC catheters.The application segment is divided into cancer, renal disease, infectious diseases, gastrointestinal diseases, and other diseases.The global end-user segment is split into hospitals, clinics, ambulatory surgical centers, home care, and others  Market InsightsMarket Research Future (MRFR) estimated that the global intravascular catheter market is set to attain a market value of USD 4, 318 million, with a CAGR of 9.3% during the forecast period (2019-2024).The Global Intravascular Catheter Market is driven by some of the various factors, such as the rising rate of hospitalization owing to the growing prevalence of infectious diseases.The increasing number of catheterization laboratories is anticipated to propel the growth of the market.On the other hand, lack of expertise and advanced medical infrastructure in developing nations is expected to restrain the growth of the global intravascular catheter market.The increasing number of surgeries for the patients under treatment for chronic diseases, rise in demand for invasive surgical procedures by using catheters at ambulatory surgical centers are some of the critical drivers propelling the growth of the global intravascular catheter market.Inadequate quality assurance, volatile pricing, and limited reimbursement in various developing nations are some the restraining factor in the global market.Increased count of surgeries for treating gastroenterology, cardiovascular, renal, and other diseases is one of the critical pointers driving the global intravascular catheter market.Browse Complte Report :https://www.marketresearchfuture.com/reports/intravascular-catheter-market-7966 Regional InsightsThe global intravascular catheter market is dominated by the Americas, owing to a rise in per capita income, heavy adoption, and increased healthcare expenditure.Growing occurrences of hospital-acquired infection and the present of advanced healthcare facilities jointly foster the market growth in the North America region.
UGC
The rising demand for ambulatory infusion pumps in home care settings, increasing incidence of chronic diseases along with the rapid growth of the geriatric population, and growing number of surgical procedures performed are the major factors driving the growth of this market.The global Infusion Pump Market is projected to reach USD 18.9 billion by 2025 from USD 13.5 billion in 2020, at a CAGR of 7.0% during the forecast period.Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=90374506  Market Segmentation:-Based on products, the Infusion Pumps Accessories Market is segmented into accessories & consumables and devices.The accessories & consumables segment is expected to grow at the highest CAGR during the forecast period.Based on product, the infusion pumps market is segmented into dedicated accessories & consumables and non-dedicated accessories & consumables.The dedicated accessories & consumables segment is expected to grow at the highest CAGR during the forecast period.Based on type, the Infusion Pumps Accessories Market has been segmented into traditional infusion pumps and specialty infusion pumps market.The specialty infusion pumps segment is expected to grow at the highest CAGR during the forecast period.Based on application, the Infusion Pumps Accessories Market is segmented into chemotherapy/oncology, diabetes, gastroenterology, analgesia/pain management, pediatrics/neonatology, hematology, and other applications (includes infectious diseases, autoimmune diseases, and diseases of the heart, kidney, lung, and liver).On the basis of end user, the infusion pumps market has been segmented into hospitals, home care settings, ambulatory care settings, and academic and research institutes.Key Market Drivers: -             1 Rising demand for ambulatory infusion pumps in home care settings             2 Increasing incidence of chronic diseases along with the rapid growth of the geriatric population             3 Growing numbers of surgical procedures performedRegional Analysis:-North America accounted for the largest share of the infusion pumps market in 2019, followed by Europe.Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=90374506 Key market Players:-The prominent players in this market are Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Fresenius Kabi (Germany), ICU Medical, Inc. (US), Medtronic plc (Ireland), Mindray Medical International Limited (China), Micrel Medical Devices SA (Greece), and Ypsomed Holding AG (Switzerland), among other key players. 
1
UGC
Market Highlights:Diagnostic imaging helps to understand the functioning of body parts and create visual representation of interior of the body and provides support in detection of medical disorder.The continues increase in geriatric population, increasing prevalence of chronic diseases, and  technological advancements are the major factors driving the growth of the global diagnostic imaging market.Additionally, increasing investment in R and aggressive strategies adopted by the major players, such as new product launches along with merger and acquisitions, are contributing to the growth of the market.For instance, in March 2017, General Electric Company announced the acquisition of Monica healthcare  for undisclosed amount, with this transaction the company will gain control over 1000 sites of Monica healthcare across Europe, Asia and north America .Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6765  The high costs associated with diagnostic imaging devices, unfavorable reimbursement policies and scarcity of technicians are likely to hinder market growth during the forecast period.Regional Analysis:The market in the Americas is expected to dominate the global diagnostic imaging market during the forecast period due to the increasing number of patients suffering from chronic diseases,  surge in geriatric population, rising prevalence of cancer, and well-established healthcare systemThe European market is expected to hold the second position in the global diagnostic imaging market owing to the government support and favorable regulatory policies, increasing medical and diagnostic centers, and increasing healthcare expenditure.Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing population and subsequently increasing chronic diseases, rising investment in healthcare and increase in disposable income.The market in the Middle East & Africa is likely to hold  the smallest share of the global diagnostic imaging market.Segmentation:The global diagnostic imaging market has been segmented on the basis of product, source, and application.Based on  product type, the market has been divided into x-ray equipment, ultrasound imaging systems, nuclear imaging systems, magnetic resonance imaging (MRI), computed tomography (CT) scanners, and other productsThe market, by application, has been segmented into gynecology, oncology, orthopedics, cardiology, gastroenterology, neurology, and other applicationsThe end-user segment has been further divided into hospitals and clinics, diagnostic centers, research institutes, and others.
UGC
Global Blood Flow Measurement Devices Market was valued US$ 413.15 Mn in 2018 and is expected to reach US$ XX Mn by 2026, at a CAGR of XX % during a forecast period.Global Blood Flow Measurement Devices MarketBlood flow measurement devices are used by the physician in the healthcare industry to monitor & measure the flow of blood in individual organs, veins, and arteries.An increased cardiovascular disorders, increasing obesity rates, growing the population of aging patients and rising demand for minimally invasive procedures is major driving factors of the market.In terms of product, global blood flow measurement devices market is classified into ultrasonic Doppler blood flow meters, laser doppler blood flow meters, and electromagnetic blood flow meters.Based on application, global blood flow measurement devices market is divided into gastroenterology, diabetes, dermatology, peripheral vascular disease, intracranial monitoring in stroke & brain injury, tumor monitoring & angiogenesis, and other.By product, ultrasonic Doppler blood flow meters dominates the blood flow measurement device market due to a rising number of clinical applications across the world.The ultrasonic blood flow meter is help for the determination of blood pressure in a more accurate way.Based on regions, the global blood flow measurement devices market is divided into five main regions are North America, Europe, Asia-pacific, South America and Middle East & Africa.Geographically, North America region holds the largest market share in blood flow measurement devices market due to increase in circulatory disorders.The Asia Pacific is forecasted to the fastest growing region during the forecast period due to rising healthcare infrastructure market across the globe.Transforming super-sensitive touch sensors, Stanford engineers and medical researchers have built a Blood Flow Measurement Devices to wirelessly monitor blood flow after surgery.A new device developed by Stanford University researchers could make it easier for doctors to monitor the success of blood vessel surgery.Key player operating in global blood flow measurement devices market are Arjohuntleigh, Inc., Atys Medical, Biomedix Inc, Cardinal Health Inc., Compumedics Ltd, Cook Medical Inc., Deltex Medical, Elcat Gmbh, Gf Health Products, Inc., Medistim Asa, Medtronics., Moor Instruments Ltd., Perimed Ab, Transonic Systems, Inc., and Viasys Healthcare.The objective of the report is to present comprehensive analysis of Global Blood Flow Measurement Devices Market including all the stakeholders of the industry.
UGC
The rising demand for ambulatory infusion pumps in home care settings, increasing incidence of chronic diseases along with the rapid growth of the geriatric population, and growing number of surgical procedures performed are the major factors driving the growth of this market.The global Infusion Pump Market is projected to reach USD 18.9 billion by 2025 from USD 13.5 billion in 2020, at a CAGR of 7.0% during the forecast period.Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=90374506  Based on products, the infusion pumps market is segmented into accessories & consumables and devices.The accessories & consumables segment is expected to grow at the highest CAGR during the forecast period.This growth can be attributed to its recurrent use and the increasing adoption of infusion pumps for the delivery of medications in a controlled environment.Based on product, the infusion pumps market is segmented into dedicated accessories & consumables and non-dedicated accessories & consumables.The dedicated accessories & consumables segment is expected to grow at the highest CAGR during the forecast period.Based on type, the infusion pump devices market has been segmented into traditional infusion pumps and specialty infusion pumps market.The specialty infusion pumps segment is expected to grow at the highest CAGR during the forecast period.Based on application, the infusion pumps market is segmented into chemotherapy/oncology, diabetes, gastroenterology, analgesia/pain management, pediatrics/neonatology, hematology, and other applications (includes infectious diseases, autoimmune diseases, and diseases of the heart, kidney, lung, and liver).The diabetes segment is expected to grow at the highest CAGR during the forecast period.On the basis of end user, the infusion pumps market has been segmented into hospitals, home care settings, ambulatory care settings, and academic and research institutes.
UGC
Market Overview According to a new report by Market Research Future (MRFR), the global Gallstone Market has been anticipated to expand at 7.9 % CAGR during the forecast period (2017-2022) owing to the increase in gallbladder diseases globally.Gallstones develop due to chemical imbalance of bile inside the gallbladder.It has been predicted that in the UK, more than one in every ten adults suffer from gallstones.Several companies are also adopting strategies for acquisitions and launching new products to strive in the competitive market.The most common type is the cholesterol gallstone which appears in yellow and is mainly composed of undissolved cholesterols.According to World Gastroenterology Organisation, more than 85 % gallstones are cholesterol stones in developed countries, among which around 20 million people in the US suffer from gallstones.Different diagnostic procedures covered in the market include abdominal CT scan, ultrasound, blood tests, gallbladder radionuclide scan, and others.
UGC
Market Highlights:Diagnostic imaging helps to understand the functioning of body parts and create visual representation of interior of the body and provides support in detection of medical disorder.The continues increase in geriatric population, increasing prevalence of chronic diseases, and  technological advancements are the major factors driving the growth of the globaldiagnostic imaging market.Additionally, increasing investment in R and aggressive strategies adopted by the major players, such as new product launches along with merger and acquisitions, are contributing to the growth of the market.For instance, in March 2017, General Electric Company announced the acquisition of Monica healthcare  for undisclosed amount, with this transaction the company will gain control over 1000 sites of Monica healthcare across Europe, Asia and north America .Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6683 The high costs associated with diagnostic imaging devices, unfavorable reimbursement policies and scarcity of technicians are likely to hinder market growth during the forecast period.Regional Analysis:The market in the Americas is expected to dominate the global diagnostic imaging market during the forecast period due to the increasing number of patients suffering from chronic diseases,  surge in geriatric population, rising prevalence of cancer, and well-established healthcare systemThe European market is expected to hold the second position in the global diagnostic imaging market owing to the government support and favorable regulatory policies, increasing medical and diagnostic centers, and increasing healthcare expenditure.Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing population and subsequently increasing chronic diseases, rising investment in healthcare and increase in disposable income.The market in the Middle East & Africa is likely to hold  the smallest share of the global diagnostic imaging market.Segmentation:The global diagnostic imaging market has been segmented on the basis of product, source, and application.Based on  product type, the market has been divided into x-ray equipment, ultrasound imaging systems, nuclear imaging systems, magnetic resonance imaging (MRI), computed tomography (CT) scanners, and other productsThe market, by application, has been segmented into gynecology, oncology, orthopedics, cardiology, gastroenterology, neurology, and other applicationsThe end-user segment has been further divided into hospitals and clinics, diagnostic centers, research institutes, and others.
2
UGC
The study also presents a precise summary of the competitive milieu, key developments, and application landscape of the Chronic Idiopathic Constipation Market based on the impact of the financial and non-financial facades of the industry.Chronic Idiopathic Constipation Treatment Market Research Report: By Diagnosis (Blood Tests, Sigmoidoscopy, Colonoscopy, Balloon Expulsion Test, Anorectal Manometry), Treatment (Drugs), End-User (Hospitals & Clinics, Diagnostic Centers) – Global Forecast Till 2023Market HighlightsThe market in Asia Pacific is expected to grow rapidly in the coming years.The other major chronic disease found in this region is the gastric cancer.SegmentationThe global Chronic Idiopathic Constipation Market is segmented on the basis of diagnosis, treatment, and end-user.On the basis of diagnosis, the market is segmented into blood tests, sigmoidoscopy, colonoscopy, balloon expulsion tests, anorectal manometry, colonic transit study, defecography, and others.Drugs are further segmented into acid neutralizers, laxatives and antidiarrheal, antiemetics, antiulcer, lubiprostone (amitiza) and linaclotide (linzess), misoprostol (Cytotec), colchicine/probenecid (Col-Probenecid) and Onabotulinumtoxin A (also called botulinum toxin type A or Botox), and others.On the basis of end-user, the market is segmented into hospitals, gastroenterology clinics, diagnostic centers, and others.Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/5931Regional AnalysisThe Americas dominates the global chronic idiopathic constipation market owing to the increasing prevalence of chronic constipation and the presence of a well-developed healthcare sector within the region.
UGC
The global active pharmaceutical ingredient (API) market size is expected to reach USD 306.1 billion by 2027 according to a new study by Polaris Market Research.The report “Active pharmaceutical Ingredient (API) market Share, Size, Trends, Industry Analysis Report, By Product Type (Monoclonal Antibodies, Immunoglobulin, Cytokines, Insulin, Peptide Hormones, Blood Factors, Peptide Antibiotics, Vaccines, Small Molecule Antibiotics, Highly Potent Active Pharmaceutical Ingredient (HPAPI), and Others); By Form (Aqueous, Non-Aqueous Liquid, and Dry Powder); By Manufacturer Type (Captive, and Merchant); By Application (Cardiology, Oncology, CNS & Neurology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, and Others), By Regions; Segment Forecast, 2020 –2027”gives a detailed insight into current market dynamics and provides analysis on future market growth.Active Pharmaceutical Ingredient (API) is a substance involved in the finished pharmaceutical product (FPP), aimed to enhance the pharmacological activity or have direct impact in the cure, mitigation, diagnosis, treatment of disease or in modifying, correcting or restoring physiological functions in the human body.The prominent factors favoring the global market include the sudden outbreak of novel corona virus, which is rapidly escalating the demand for pharmaceuticals and thereby fueling the overall market growth.Additionally, rise in aging population, rising cases of cardiovascular diseases, cancer, AIDs, other infectious diseases, are further contributing to augmenting demand for APIs that are used in drugs.Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/active-pharmaceutical-ingredients-market/request-for-sample Market participants such as AbbVie Inc., Albemarle Corporation, AstraZeneca, Aurobindo Pharma, Boehringer Ingelheim, Bristol-Myers Squibb, Cipla Inc., Dr. Reddy’s Laboratories Ltd., ELI Lilly and Company, F. Hoffmann-La Roche, GlaxoSmithKline PLC, Lonza Group, Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer, Inc., Sanofi, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd. are some of the key players operating in the global market.
UGC
The global Medical Device Coatings market was valued at $XX million in 2018, and Radiant Insights, Inc. analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.This report provides detailed historical analysis of global market for Medical Device Coatings from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors.Download Free Sample Report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-medical-device-coatings-market/request-sample Leading players of Medical Device Coatings including: • DSM Biomedical• Surmodics• SCS• Biocoat• Covestro• Coatings2Go• Thermal Spray Technologies• Hydromer• Harland Medical Systems• AST Products• Precision Coating• Surface Solutions Group• ISurTec• Whitford• AdvanSource Biomaterials Market split by Type, can be divided into: • Hydrophilic Coatings• Antimicrobial Coatings• Drug Delivery Coatings• Others Market split by Application, can be divided into: • Cardiovascular• Orthopedic Implants• Surgical Instruments• Urology & Gastroenterology• Others Market split by Sales Channel, can be divided into: • Direct Channel• Distribution Channel Market segment by Region/Country including: • North America (United States, Canada and Mexico)• Europe (Germany, UK, France, Italy, Russia and Spain etc.)• Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)• Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)Browse Full Research Report with TOC @ https://www.radiantinsights.com/research/2013-2028-report-on-global-medical-device-coatings-market Table of Contents Chapter 1 Medical Device Coatings Market Overview1.1 Medical Device Coatings Definition1.2 Global Medical Device Coatings Market Size Status and Outlook (2013-2028)1.3 Global Medical Device Coatings Market Size Comparison by Region (2013-2028)1.4 Global Medical Device Coatings Market Size Comparison by Type (2013-2028)1.5 Global Medical Device Coatings Market Size Comparison by Application (2013-2028)1.6 Global Medical Device Coatings Market Size Comparison by Sales Channel (2013-2028)1.7 Medical Device Coatings Market Dynamics1.7.1 Market Drivers/Opportunities1.7.2 Market Challenges/Risks1.7.3 Market News (Mergers/Acquisitions/ Expansion) Chapter 2 Medical Device Coatings Market Segment Analysis by Player2.1 Global Medical Device Coatings Sales and Market Share by Player (2016-2018)2.2 Global Medical Device Coatings Revenue and Market Share by Player (2016-2018)2.3 Global Medical Device Coatings Average Price by Player (2016-2018)2.4 Players Competition Situation & Trends2.5 Conclusion of Segment by Player Chapter 3 Medical Device Coatings Market Segment Analysis by Type3.1 Global Medical Device Coatings Market by Type3.1.1 Hydrophilic Coatings3.1.2 Antimicrobial Coatings3.1.3 Drug Delivery Coatings3.1.4 Others3.2 Global Medical Device Coatings Sales and Market Share by Type (2013-2018)3.3 Global Medical Device Coatings Revenue and Market Share by Type (2013-2018)3.4 Global Medical Device Coatings Average Price by Type (2013-2018)3.5 Leading Players of Medical Device Coatings by Type in 20183.6 Conclusion of Segment by Type Continued… Read all Reports of this category @ https://www.radiantinsights.com/catalog/chemicals-and-materials About Radiant InsightsRadiant Insights is a platform for companies looking to meet their market research and business intelligence requirements.
UGC
Market Overview According to a new report by Market Research Future (MRFR), the global Gallstone Market has been anticipated to expand at 7.9 % CAGR during the forecast period (2017-2022) owing to the increase in gallbladder diseases globally.Gallstones develop due to chemical imbalance of bile inside the gallbladder.It has been predicted that in the UK, more than one in every ten adults suffer from gallstones.Several companies are also adopting strategies for acquisitions and launching new products to strive in the competitive market.The most common type is the cholesterol gallstone which appears in yellow and is mainly composed of undissolved cholesterols.According to World Gastroenterology Organisation, more than 85 % gallstones are cholesterol stones in developed countries, among which around 20 million people in the US suffer from gallstones.Different diagnostic procedures covered in the market include abdominal CT scan, ultrasound, blood tests, gallbladder radionuclide scan, and others.
UGC
Adroit Centre for Digestive and Obesity surgery is one of the best gastroenterology in India.The aim of our specialized hospital is to make quality gastroenterology treatment accessible to everyone.
More

Top